HHealthcare Read More BioAge shows promise with new drug BGE-102 in early trialDecember 8, 2025 The company expands its Phase 1 trial after early signals show BGE-102’s potential to address inflammation beyond the…
HHealthcare Read More Startup aims to ‘decode aging’ with immune-profiling AIAugust 17, 2025 Omniscope launches osLongevity in pivot from immune system research applications into consumer longevity and prevention. TechBio startup Omniscope…